Reaction
Diffuse Alopecia reporting signals
As of the last recalculation, Diffuse Alopecia appears in 1,846 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TOFACITINIB CITRATE (PRR 20.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tofacitinib Citrate | 23 | 20.0 | 20.1 |
| Levonorgestrel | 211 | 13.2 | 13.2 |
| Docetaxel Anhydrous | 62 | 10.7 | 10.7 |
| Docetaxel | 62 | 10.7 | 10.7 |
| Telmisartan | 15 | 9.5 | 9.6 |
| Busulfan | 9 | 6.5 | 6.5 |
| Thiotepa | 5 | 5.9 | 5.9 |
| Sevelamer Carbonate | 6 | 5.9 | 5.9 |
| Ixekizumab | 19 | 5.8 | 5.8 |
| Vismodegib | 4 | 5.1 | 5.1 |
| Ifosfamide | 9 | 4.7 | 4.7 |